| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
OCPH Stock Overview
October Pharma S.A.E manufactures and sells pharmaceutical products.
October Pharma S.A.E Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م79.98 |
| 52 Week High | ج.م87.50 |
| 52 Week Low | ج.م57.51 |
| Beta | -0.012 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 39.07% |
| 3 Year Change | 142.35% |
| 5 Year Change | 127.17% |
| Change since IPO | 1,583.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| OCPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 0% | 9.0% | 7.0% |
| 1Y | 39.1% | 19.7% | 19.3% |
Return vs Industry: OCPH exceeded the EG Pharmaceuticals industry which returned 19.7% over the past year.
Return vs Market: OCPH exceeded the EG Market which returned 19.3% over the past year.
Price Volatility
| OCPH volatility | |
|---|---|
| OCPH Average Weekly Movement | 0% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in EG Market | 9.0% |
| 10% least volatile stocks in EG Market | 3.6% |
Stable Share Price: OCPH is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 0% a week.
Volatility Over Time: OCPH's weekly volatility (0%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | n/a | https://www.octoberpharma.com |
October Pharma S.A.E manufactures and sells pharmaceutical products. The company offers cardiovascular, CNS, cold and chest, dermatology, diabetology, gastroenterology, hepatology, NSAID’s, and urology medicines, as well as antibiotics and multivitamins. It provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials.
October Pharma S.A.E Fundamentals Summary
| OCPH fundamental statistics | |
|---|---|
| Market Cap | ج.م479.85m |
| Earnings (TTM) | ج.م119.79m |
| Revenue (TTM) | ج.م655.04m |
4.0x
P/E Ratio0.7x
P/S RatioIs OCPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OCPH income statement (TTM) | |
|---|---|
| Revenue | ج.م655.04m |
| Cost of Revenue | ج.م331.75m |
| Gross Profit | ج.م323.29m |
| Other Expenses | ج.م203.50m |
| Earnings | ج.م119.79m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 19.97 |
| Gross Margin | 49.35% |
| Net Profit Margin | 18.29% |
| Debt/Equity Ratio | 21.5% |
How did OCPH perform over the long term?
See historical performance and comparison